Tirzepatide works like other drugs in the GLP-1 family but contains an extra molecule that gives a slight advantage. With the combination of two different peptides, the drug has a dual-action design, making it the first medication in its class to work on both receptors at the same time. It works as a dual GLP-1 agonist and GIP agonist to maximize similar benefits that are seen with GLP-1 medications, such as Semaglutide. Adding GIP helps improve blood sugar levels and reduce hunger, beyond what Semaglutide can do on its own.
For patients who have tried Semaglutide and are looking for an alternative that can provide even more benefits; Tirzepatide may be the solution for you. Tirzepatide replicates the peptide produced by the body when full, slowing down the digestion process, ensuring the feeling of being full for longer, thus reducing the urge to eat.